The Gujarat Kidney and Super Speciality IPO, priced between Rs 108-114 per share, closed with a subscription of 5.21 times. Retail investors showed strong demand, subscribing 19.04 times, while QIBs subscribed 1.06 times. The basis of allotment is expected on December 26, with refunds and demat credits on December 29, and listing on BSE and NSE on December 30. Proceeds will fund hospital acquisitions, capital expenditure, and debt repayment. The grey market premium is currently nil, suggesting a flat listing.